Artelo Biosciences (ARTL) Cash & Equivalents (2014 - 2026)
Artelo Biosciences (ARTL) posted Cash & Equivalents of $10.27 million for Q1 2026, compared with $746,000 a year earlier.
Powered by 
Analysis
Artelo Biosciences (ARTL) Cash & Equivalents (2014 - 2026) Analysis & Trends
At the end of FY2025, Artelo Biosciences' Cash & Equivalents came in at $600,000, down 74.3% from FY2024.
- Annual Cash & Equivalents has declined for four consecutive years, with a five-year compound annual growth rate of -22.5% (FY2020 to FY2025).
- In prior years, Artelo Biosciences' Cash & Equivalents was $2.34 million in FY2024 (-16.9%), $2.82 million in FY2023 (-59.1%), $6.89 million in FY2022 (-43.4%) and $12.16 million in FY2021.
- The Q1 2026 figure stands as the highest quarterly Cash & Equivalents since Q2 2022.
- On a year-over-year basis, Cash & Equivalents increased in two of the last seven quarters, with an average decline of 10.6%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q3 2021, with growth of 685.8%; the weakest was Q2 2024, with a decline of 84.6%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $600,000 (Q4 2025), $1.72 million (Q3 2025) and $2.07 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Artelo Biosciences | 49.32 Mn | 32.53 Mn | - | 4.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.20 Mn |
| Mar 31, 2026 | 10.27 Mn |
| Dec 31, 2025 | 600,000.00 |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Mar 31, 2025 | 746,000.00 |
| Dec 31, 2024 | 2.34 Mn |
| Sep 30, 2024 | 4.36 Mn |
| Jun 30, 2024 | 881,000.00 |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 2.82 Mn |
| Sep 30, 2023 | 2.64 Mn |
| Jun 30, 2023 | 5.72 Mn |
| Mar 31, 2023 | 6.92 Mn |
| Dec 31, 2022 | 6.89 Mn |
| Sep 30, 2022 | 7.14 Mn |
| Jun 30, 2022 | 12.12 Mn |
| Mar 31, 2022 | 10.35 Mn |
| Nov 30, 2021 | 14.05 Mn |
| Aug 31, 2021 | 6.63 Mn |
API Access
Artelo Biosciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();